Krasner Alan Seth 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Krasner Alan Seth
Chief Medical Officer
Transactions
- Award
Common Stock
2023-03-01+19,500→ 43,988 total - Award
Common Stock (right to buy)
2023-03-01+91,000→ 91,000 totalExercise: $19.64Exp: 2033-02-28→ Common Stock (91,000 underlying)
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023.